Ryann Muir represents major pharmaceutical and biotechnology companies in high profile patent matters involving pharmaceutical and biotechnology products, molecular diagnostics, biochemical research tools, and chemical manufacturing processes. Ryann focuses her practice on complex patent litigation, counseling, and intellectual property transactions.
Ryann has litigated patent cases in federal courts throughout the country, and has managed teams through all phases of litigation including summary judgment motions, claim construction (Markman) proceedings, trials, and Federal Circuit appeals. She also has extensive experience in pre-suit investigations, opinions of counsel, due diligence, and USPTO post-grant proceedings, including inter partes reviews (IPRs).
Prior to practicing law, Ryann was a molecular biologist where she studied the synthesis of large molecules in different protein expression systems.
Bar & Court Admissions: New York
- J.D., Boston University School of Law, 2008, cum laude; Managing Editor, Journal of Science & Technology Law
- Ph.D., University of California, Davis, 2005, Biological Sciences & Biotechnology
- B.S., University of California, Davis, 1998, Plant Biology
Rate : $$$